Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases

Roshni Iyer, Aneetta E. Kuriakose, Serkan Yaman, Lee Chun Su, Dingying Shan, Jian Yang, Jun Liao, Liping Tang, Subhash Banerjee, Hao Xu, Kytai T. Nguyen

Research output: Contribution to journalArticle

Abstract

Nanoparticles (NPs) can be used to locally deliver anti-restenosis drugs when they are infused directly to the injured arteries after intervention procedures such as angioplasty. However, the efficacy of transferring NPs via infusion to the arterial wall is limited, at least partially, due to poor NP retention on the inner artery wall. To improve NP retention, angioplasty balloons coated with drug-loaded NPs were fabricated via either layer-by-layer (LbL) electrostatic coating or acrylic-based hydrogel (AAH) coating techniques. Three types of NPs, namely poly (lactide-co-glycolide) (PLGA), biodegradable photo-luminescent PLGA and urethane doped polyester were studied. The transfer efficacy of NPs from various coatings to the arterial wall were further evaluated to find the optimal coating conditions. The ex vivo NP transfer studies showed significantly more NPs being transferred to the rat arterial wall after the angioplasty procedure by the AAH coating (95% transfer efficiency) compared to that of the LbL technique (60%) and dip coating (20%) under flow conditions (10 dyn/cm2). Our results suggest that the AAH coating of drug-loaded NPs on the angioplasty balloon could potentially provide superior retention of drug-loaded NPs onto the arterial wall for a better local delivery of drug-loaded NPs to effectively treat arterial diseases.

LanguageEnglish (US)
Pages212-223
Number of pages12
JournalInternational Journal of Pharmaceutics
Volume554
DOIs
StatePublished - Jan 10 2019

Fingerprint

Balloon Angioplasty
Nanoparticles
Cardiovascular Diseases
Hydrogel
Pharmaceutical Preparations
Angioplasty
Arteries
Polyglactin 910
Polyesters
Urethane
Static Electricity

Keywords

  • Angioplasty balloon coating
  • Drug eluting balloons
  • Hydrogel
  • Layer-by-layer
  • Nanoparticle coating

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Iyer, R., Kuriakose, A. E., Yaman, S., Su, L. C., Shan, D., Yang, J., ... Nguyen, K. T. (2019). Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases. International Journal of Pharmaceutics, 554, 212-223. https://doi.org/10.1016/j.ijpharm.2018.11.011

Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases. / Iyer, Roshni; Kuriakose, Aneetta E.; Yaman, Serkan; Su, Lee Chun; Shan, Dingying; Yang, Jian; Liao, Jun; Tang, Liping; Banerjee, Subhash; Xu, Hao; Nguyen, Kytai T.

In: International Journal of Pharmaceutics, Vol. 554, 10.01.2019, p. 212-223.

Research output: Contribution to journalArticle

Iyer, R, Kuriakose, AE, Yaman, S, Su, LC, Shan, D, Yang, J, Liao, J, Tang, L, Banerjee, S, Xu, H & Nguyen, KT 2019, 'Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases' International Journal of Pharmaceutics, vol. 554, pp. 212-223. https://doi.org/10.1016/j.ijpharm.2018.11.011
Iyer, Roshni ; Kuriakose, Aneetta E. ; Yaman, Serkan ; Su, Lee Chun ; Shan, Dingying ; Yang, Jian ; Liao, Jun ; Tang, Liping ; Banerjee, Subhash ; Xu, Hao ; Nguyen, Kytai T. / Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases. In: International Journal of Pharmaceutics. 2019 ; Vol. 554. pp. 212-223.
@article{b30654f309c240e697a47605eed490f7,
title = "Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases",
abstract = "Nanoparticles (NPs) can be used to locally deliver anti-restenosis drugs when they are infused directly to the injured arteries after intervention procedures such as angioplasty. However, the efficacy of transferring NPs via infusion to the arterial wall is limited, at least partially, due to poor NP retention on the inner artery wall. To improve NP retention, angioplasty balloons coated with drug-loaded NPs were fabricated via either layer-by-layer (LbL) electrostatic coating or acrylic-based hydrogel (AAH) coating techniques. Three types of NPs, namely poly (lactide-co-glycolide) (PLGA), biodegradable photo-luminescent PLGA and urethane doped polyester were studied. The transfer efficacy of NPs from various coatings to the arterial wall were further evaluated to find the optimal coating conditions. The ex vivo NP transfer studies showed significantly more NPs being transferred to the rat arterial wall after the angioplasty procedure by the AAH coating (95{\%} transfer efficiency) compared to that of the LbL technique (60{\%}) and dip coating (20{\%}) under flow conditions (10 dyn/cm2). Our results suggest that the AAH coating of drug-loaded NPs on the angioplasty balloon could potentially provide superior retention of drug-loaded NPs onto the arterial wall for a better local delivery of drug-loaded NPs to effectively treat arterial diseases.",
keywords = "Angioplasty balloon coating, Drug eluting balloons, Hydrogel, Layer-by-layer, Nanoparticle coating",
author = "Roshni Iyer and Kuriakose, {Aneetta E.} and Serkan Yaman and Su, {Lee Chun} and Dingying Shan and Jian Yang and Jun Liao and Liping Tang and Subhash Banerjee and Hao Xu and Nguyen, {Kytai T.}",
year = "2019",
month = "1",
day = "10",
doi = "10.1016/j.ijpharm.2018.11.011",
language = "English (US)",
volume = "554",
pages = "212--223",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",

}

TY - JOUR

T1 - Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases

AU - Iyer, Roshni

AU - Kuriakose, Aneetta E.

AU - Yaman, Serkan

AU - Su, Lee Chun

AU - Shan, Dingying

AU - Yang, Jian

AU - Liao, Jun

AU - Tang, Liping

AU - Banerjee, Subhash

AU - Xu, Hao

AU - Nguyen, Kytai T.

PY - 2019/1/10

Y1 - 2019/1/10

N2 - Nanoparticles (NPs) can be used to locally deliver anti-restenosis drugs when they are infused directly to the injured arteries after intervention procedures such as angioplasty. However, the efficacy of transferring NPs via infusion to the arterial wall is limited, at least partially, due to poor NP retention on the inner artery wall. To improve NP retention, angioplasty balloons coated with drug-loaded NPs were fabricated via either layer-by-layer (LbL) electrostatic coating or acrylic-based hydrogel (AAH) coating techniques. Three types of NPs, namely poly (lactide-co-glycolide) (PLGA), biodegradable photo-luminescent PLGA and urethane doped polyester were studied. The transfer efficacy of NPs from various coatings to the arterial wall were further evaluated to find the optimal coating conditions. The ex vivo NP transfer studies showed significantly more NPs being transferred to the rat arterial wall after the angioplasty procedure by the AAH coating (95% transfer efficiency) compared to that of the LbL technique (60%) and dip coating (20%) under flow conditions (10 dyn/cm2). Our results suggest that the AAH coating of drug-loaded NPs on the angioplasty balloon could potentially provide superior retention of drug-loaded NPs onto the arterial wall for a better local delivery of drug-loaded NPs to effectively treat arterial diseases.

AB - Nanoparticles (NPs) can be used to locally deliver anti-restenosis drugs when they are infused directly to the injured arteries after intervention procedures such as angioplasty. However, the efficacy of transferring NPs via infusion to the arterial wall is limited, at least partially, due to poor NP retention on the inner artery wall. To improve NP retention, angioplasty balloons coated with drug-loaded NPs were fabricated via either layer-by-layer (LbL) electrostatic coating or acrylic-based hydrogel (AAH) coating techniques. Three types of NPs, namely poly (lactide-co-glycolide) (PLGA), biodegradable photo-luminescent PLGA and urethane doped polyester were studied. The transfer efficacy of NPs from various coatings to the arterial wall were further evaluated to find the optimal coating conditions. The ex vivo NP transfer studies showed significantly more NPs being transferred to the rat arterial wall after the angioplasty procedure by the AAH coating (95% transfer efficiency) compared to that of the LbL technique (60%) and dip coating (20%) under flow conditions (10 dyn/cm2). Our results suggest that the AAH coating of drug-loaded NPs on the angioplasty balloon could potentially provide superior retention of drug-loaded NPs onto the arterial wall for a better local delivery of drug-loaded NPs to effectively treat arterial diseases.

KW - Angioplasty balloon coating

KW - Drug eluting balloons

KW - Hydrogel

KW - Layer-by-layer

KW - Nanoparticle coating

UR - http://www.scopus.com/inward/record.url?scp=85056450845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056450845&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2018.11.011

DO - 10.1016/j.ijpharm.2018.11.011

M3 - Article

VL - 554

SP - 212

EP - 223

JO - International Journal of Pharmaceutics

T2 - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

ER -